---
title: 'Director, HCP Marketing at Bicara Therapeutics'
canonical: 'https://feeny.ai/job/director-hcp-marketing-bicara-therapeutics-boston-zk7mwe36qb8x'
type: 'job'
last_seen: '2026-10-18'
---

# Director, HCP Marketing at Bicara Therapeutics

- **Company:** Bicara Therapeutics
- **Location:** Boston, MA
- **Employment:** full-time
- **Work type:** hybrid
- **Posted:** 2026-10-16
- **Last confirmed live:** 2026-10-18
- **Apply:** https://jobs.ashbyhq.com/bicara-therapeutics/89cb561f-cac1-4cd7-b79b-4beba030d751

## Job description

Position Overview Bicara Therapeutics is seeking a Director, Healthcare Professional Marketing (HCP) Lead to develop, lead, and execute HCP marketing strategy and promotions for Bicara’s lead candidate, Ficerafusp Alfa. The HCP marketing director will be a critical part of the launch readiness team and work closely with the Senior Director, Marketing to develop commercial HCP promotion strategy and tactical plans for Ficerafusp Alfa in Head and Neck Squamous Cell Carcinoma (HNSCC) within the US.

This is a high-impact, highly visible role that partners closely with Commercial Strategy, Commercial Operations, Market Access, Medical Affairs, Insights & Analytics, Legal & Compliance, Competitive Intelligence, Sales, and Training. This role will also involve managing agency partners and overseeing workstreams that involve broad and meaningful internal and external collaboration.

This role is based in our Boston office and follows a hybrid schedule, with three in-office days each week.

## Responsibilities

- Lead HCP marketing strategy for Ficerafusp Alfa’s lead indication in 1L R/M HPV-negative HNSCC as Bicara prepares for potential US FDA approval. This includes developing an understanding and assessment of the US market opportunity, gathering insights to inform sources of business and market opportunities, analyzing competitive landscape, identifying key site of care and key account segmentation needs, developing customer-focused and differentiated product and indication positioning, and tailoring messages to key target audiences.
- Develop and execute the HCP launch plan across key channels, including personal promotion, digital/media marketing, peer-to-peer promotions, and congress.
- Lead the development of the HCP messaging platform, from end-to-end, including the development of the core visual aid, derivative materials for personal and non-personal promotion, and pull-through across training and resource roll-out initiatives.
- Oversee HCP Digital/Media strategy and execution for development, implementation, and optimization of the multi-channel marketing mix, including omnichannel digital and media strategy and implementation, and creation and deployment of educational resources towards brand objectives and KPIs across key audiences.
- Serve as a resource and collaborate with medical affairs, field medical, commercial strategy and market development, commercial field teams, and ensure alignment of HCP strategy, launch objectives, key messaging, and functional roadmaps.
- Engage with physician experts, including but not limited to Key Opinion Leaders (KOLs), Regional opinion leaders, and key community stakeholders to identify critical market needs and opportunities.
- Partner with sales training and field leadership to develop learning standards, provide input on learning modules, and product certifications.
- Ensure compliant marketing processes, programs, and internal reports are developed, implemented, and effectively administered to be consistent with corporate guidance and all regulatory, legal, ethical guidelines.
- Manage and track budget spend to ensure operations stay within approved budget and phasing.

## Qualifications

- Bachelor’s degree required; advanced degree preferred.
- 8+ years of experience in biopharma, marketing, or other commercial roles.
- Oncology experience required (new product launch experience preferred).
- Experience operating in evolving market and organizational dynamics.
- Strong clinical, scientific, marketing, and oncology business acumen.
- Experience developing brand plans in support of business objectives.
- Strong communication and cross-functional leadership skills.
- Alignment with Bicara's core values.
- Ability to travel up to 25% of the time.

Company Overview Bicara Therapeutics is a clinical-stage biotech company pioneering bifunctional antibodies for targeted tumor modulation. Founded in 2020, we've built a global team of over 100 employees headquartered in Boston, with a clear focus on advancing our lead asset, ficerafusp alfa, or FICERA - a potentially first-in-class bifunctional EGFR-directed antibody combined with a TGF-β ligand trap. Our innovative approach combines tumor-targeting with tumor modulation, where one arm localizes to the tumor while the other serves as a modulator, designed to deliver superior efficacy, improved safety, and enhanced durability directly at the tumor site. FICERA specifically addresses a key challenge in solid tumor treatment by enabling immune cell penetration into tumors, reducing fibrosis and immunosuppression while reversing TGF-β-driven resistance mechanisms - ultimately designed to drive the deep, durable responses that may translate into better outcomes and survival for patients. For more information, please visit [www.bicara.com](http://www.bicara.com). Here at Bicara, we believe in building diverse teams and cultivating a culture where all voices are included. We encourage people from all backgrounds to apply. Bicara Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.

## About Bicara Therapeutics

## Company Overview
- **One-liner**: Bicara Therapeutics is a clinical-stage biotechnology company developing first-in-class bifunctional antibodies that combine tumor-targeting with tumor microenvironment modulation, with a lead asset in head and neck squamous cell carcinoma.
- **Entity Type**: Public (NASDAQ: BCAX)
- **Headquarters**: Boston, Massachusetts, USA
- **Founded**: 2020
- **Founders**: Not publicly listed

## Core Business
- **Industry**: Biotechnology – oncology drug development
- **Target Customers**: B2B (pharma partnerships, licensing) and ultimately cancer patients and healthcare providers
- **Mission**: "Dedicated to improving the lives of people living with cancer through the development of innovative targeted therapies… bringing hope and control back into their lives." [bicara.com](https://www.bicara.com/)

## Products & Services
- **[Ficerafusp alfa (BCA101)](https://www.bicara.com/)**: First-in-class, dual-action bifunctional antibody targeting EGFR and containing a TGF-β ligand trap. Currently in Phase 1/1b clinical development for HPV-negative head and neck squamous cell carcinoma and other solid tumors. Mechanism designed to deliver an immunomodulatory payload directly to the tumor microenvironment, reduce fibrosis/immunosuppression, and enable immune cell penetration. (Biologic, clinical-stage therapeutic)

## Market Standing
- **Valuation/Market Cap**: ~$1.3 billion (as of mid-2026) [linkedin.com](https://www.linkedin.com/company/bicara-therapeutics)
- **Key Metric**: Total funding raised $825M (includes Series C $165M led by The Rise Fund and TPG, $362M from 2024 IPO, and a $150M post-IPO equity round in February 2026) [linkedin.com](https://www.linkedin.com/company/bicara-therapeutics)
- **Notable Investors/Partners**: The Rise Fund, TPG, Biocon (seed round). Additional institutional investors from IPO and follow-on offerings.
- **Growth Signals**: IPO completed September 2024; headcount grew 78.1% year-over-year (95 employees, though LinkedIn notes a slight monthly decline of -0.9%); operates across 8 countries including the UK, Italy, Germany, India, and Spain; 11 active job postings as of mid-2026. [linkedin.com](https://www.linkedin.com/company/bicara-therapeutics)

## Competitive Advantages
- **First-in-class bifunctional approach**: By combining an EGFR-targeting antibody with a TGF-β trap, BCA101 directly addresses a key solid-tumor resistance mechanism (TGF-β-driven immunosuppression and fibrosis) while localizing therapy to the tumor.
- **Potential for superior efficacy and safety**: Designed to deliver synergistic therapeutic impact at the tumor site, aiming for deep, durable responses with reduced systemic toxicity.
- **Experienced leadership**: Team with deep oncology drug development backgrounds and relationships with top cancer centers. [bicara.com/about](https://www.bicara.com/about/)

## Strategic Focus
- **Priority**: Advancing ficerafusp alfa through clinical development toward potential regulatory approvals, initially in HPV-negative head and neck squamous cell carcinoma.
- **Pipeline expansion**: Leveraging the bifunctional antibody platform (BCA101 and follow-on programs) to address multiple solid tumor types.
- **Commercial readiness**: Hiring senior roles in medical affairs, quality, regulatory, and commercial operations signals preparation for launch. [bicara.com/careers](https://www.bicara.com/careers/)

## Why Work Here
- **Culture & Mission**: A patient-first, mission-driven environment focused on developing meaningful new therapies for cancer. Company describes itself as "dynamic" with a shared passion for advancing science. [bicara.com](https://www.bicara.com/)
- **Diversity & Inclusion**: Explicitly states commitment to building diverse teams and encourages applicants from all backgrounds. [bicara.com/careers](https://www.bicara.com/careers/)
- **Growth Trajectory**: Fast-growing public company (78% headcount growth YoY) with a strong balance sheet, offering career progression opportunities.
- **Work Environment**: Headquarters in Boston with a global presence. Specific remote/hybrid policy not publicly detailed, but the company employs staff across 8 countries. Glassdoor rating of 4.0/5 on LinkedIn based on limited reviews. [linkedin.com](https://www.linkedin.com/company/bicara-therapeutics)
- **Engagement**: Active hiring across multiple senior-level roles in medical affairs, regulatory, quality, IT, and clinical operations, indicating a ramp-up toward commercialization. [bicara.com/careers](https://www.bicara.com/careers/)

## Sources
1. [bicara.com](https://www.bicara.com/) – Company home page, product, mission
2. [bicara.com/about](https://www.bicara.com/about/) – Leadership team, technology description
3. [bicara.com/careers](https://www.bicara.com/careers/) – Open positions, culture, diversity statement
4. [linkedin.com/company/bicara-therapeutics](https://www.linkedin.com/company/bicara-therapeutics) – Headcount, financials, stock info, employee reviews, talent sources
5. [massbio.org/members/bicara-therapeutics](https://www.massbio.org/members/bicara-therapeutics/) – Membership description, pipeline summary

## Other roles at Bicara Therapeutics

- [Senior Director, Brand Lead - US](https://feeny.ai/job/senior-director-brand-lead-us-bicara-therapeutics-boston-yqp846bk5xaz) — Boston, MA
- [Associate Director, Financial Planning & Analysis (Development Finance Business Partner)](https://feeny.ai/job/associate-director-financial-planning-analysis-development-finance-business-nt8nz0xbxns1) — Boston, MA
- [Senior Clinical Trial Manager](https://feeny.ai/job/senior-clinical-trial-manager-bicara-therapeutics-united-states-38pe6ec19gct) — United States
- [Manager, GxP Document Control and Quality Systems](https://feeny.ai/job/manager-gxp-document-control-and-quality-systems-bicara-therapeutics-boston-ex6dqcwrv6gy) — Boston, MA
- [Director, Biostatistics](https://feeny.ai/job/director-biostatistics-bicara-therapeutics-boston-8acrty1k88h7) — Boston, MA
- [Director, Marketing Operations](https://feeny.ai/job/director-marketing-operations-bicara-therapeutics-boston-308n8g5t9f73) — Boston, MA
- [Senior Medical Science Liaison - West (CA, WA)](https://feeny.ai/job/senior-medical-science-liaison-west-ca-wa-bicara-therapeutics-united-states-tv5xs4prg9y2) — United States
- [Senior Manager, Accounting and SEC Reporting](https://feeny.ai/job/senior-manager-accounting-and-sec-reporting-bicara-therapeutics-boston-hngf1v66tht9) — Boston, MA
- [Associate Director, Global Scientific Communications](https://feeny.ai/job/associate-director-global-scientific-communications-bicara-therapeutics-boston-b20sj17zmqbw) — Boston, MA